i
n
f
l
a
r
x
Loading
Loading
InflaRx Presentation:
Speaker: Prof. Dr. Renfeng Guo, Chief Scientific Officer and Co-founder of InflaRx
Date: Wednesday, September 28th
Presentation: "Treatment of Critically Ill COVID-19 Patients with Vilobelimab, a First-in-Class Anti-C5a Antibody"